logo image

HIV Molecular Immunology Database

Search Antibody Database

Found 1 matching record:

Displaying record number 230

Download this epitope record as JSON.

MAb ID anti-HIV-1 RT
HXB2 Location Pol Pol Epitope Map
Author Location RT
Epitope
Ab Type  
Neutralizing  
Species (Isotype) mouse(IgG)
Patient  
Immunogen  
Keywords  

Notes

Showing 2 of 2 notes.

References

Showing 3 of 3 references.

Veronese1986 F. di Marzo Veronese, T. D. Copeland, A. L. DeVico, R. Rahman, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV. Science, 231:1289-1291, 1986. This study identified the 66 and 51 kilodaltons bands in western blots as RT. Enzymatic activity was shown, and the protein was defined by Edmund N-terminal degradation and comparison to HIV-1 pol nucleotide translation. A mouse hybridoma was generated that inhibited enzyme activity. PubMed ID: 2418504. Show all entries for this paper.

Maciejewski1995 J. P. Maciejewski, F. F. Weichold, N. S. Young, A. Cara, D. Zella, M. S. Reitz, Jr., and R. C. Gallo. Intracellular Expression of Antibody Fragments Directed against HIV Reverse Transcriptase Prevents HIV Infection In Vitro. Nat. Med., 1:667-673, 1995. Transduction of genes that encode and express anti-RT Fab inhibit the enzyme, making cells resistant to HIV infection by blocking an early stage of viral replication. The authors propose that if transduction of a vector into lymphohaematopoietic stem cells or mature lymphocytes becomes feasible, gene transfer therapy has promise for treating AIDS. PubMed ID: 7585149. Show all entries for this paper.

Wainberg1995 M. A. Wainberg and Z. Gu. Targeting HIV Reverse Transcriptase in Novel Ways. Nat. Med., 1:628-629, 1995. Commentary on Maciejewski et al., 1995. PubMed ID: 7585138. Show all entries for this paper.


This is a legacy search page. It is deprecated, will receive no more updates, and will eventually be removed. Please use the new search pages.

Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
Copyright Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services LANL logo National Institutes of Health logo